BMX — BioMaxima SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapContrarian

Annual income statement for BioMaxima SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	PAS	PAS	PAS	PAS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	31.6	30.8	30.5	61.6	81.1
Cost of Revenue
Gross Profit	13.1	13.3	13	23.9	32.1
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	30.6	31.1	29.9	52.2	68.1
Operating Profit	1.01	-0.302	0.629	9.4	13
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.926	-0.532	0.182	8.75	12.8
Provision for Income Taxes
Net Income After Taxes	0.838	-0.462	0.014	7.33	10.2
Minority Interest
Net Income Before Extraordinary Items
Net Income	0.806	-0.482	-0.014	7.36	10.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.806	-0.482	-0.014	7.36	10.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.235	-0.068	0.026	1.8	2.41
Dividends per Share

Discover the metrics influencing BioMaxima SA's share price